Hoth Therapeutics (HOTH) News Today → He Is Giving Away Bitcoin (From Crypto Swap Profits) (Ad) Free HOTH Stock Alerts $1.20 +0.01 (+0.84%) (As of 05/8/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineHoth Therapeutics to Attend EF Hutton Annual Global Conference, May 15, 2024prnewswire.com - May 1 at 8:00 AMHoth Therapeutics files to sell 5.03M shares of common stock for holdersmsn.com - April 12 at 10:24 AMThe Brickyard, Carlisle to welcome popular rock band Elias T Hothmsn.com - April 2 at 11:13 PMHoth Therapeutics Announces Exercise of Warrants for $4.2 Million Gross Proceedsprnewswire.com - March 27 at 2:00 PMHoth Therapeutics' Wholly Owned Subsidiary Merveille.ai, Advances AI-Driven Discovery for Obesity Treatmentprnewswire.com - March 27 at 8:27 AMHoth Therapeutics Shares Soar on Positive Data from Alzheimer's Studymarketwatch.com - March 19 at 9:04 PMWhy Is Alzheimer's-Focused Hoth Therapeutics Stock Trading Higher On Tuesday?msn.com - March 19 at 4:03 PMHoth Therapeutics, Inc.: Hoth Therapeutics Announces Positive Data In Completed Study of Alzheimer's Disease Pre-Clinical Treatment with HT-ALZfinanznachrichten.de - March 19 at 11:03 AMGraphite Bio, SCWorx, Acurx Pharmaceuticals among healthcare moversmsn.com - March 19 at 11:03 AMHoth Therapeutics: Pre-clinical Research Shows HT-ALZ's Profound Impact On Alzheimer's Pathologymarkets.businessinsider.com - March 19 at 11:03 AMHoth stock rallies 24% on preclinical Alzheimer's datamsn.com - March 19 at 11:03 AMHoth Therapeutics Announces Positive Data In Completed Study of Alzheimer's Disease Pre-Clinical Treatment with HT-ALZprnewswire.com - March 19 at 8:21 AMHoth Therapeutics Retains Venable LLP to Expand Its Patent Portfoliofinance.yahoo.com - February 29 at 12:44 PMHoth Therapeutics, Inc.: Hoth Therapeutics Engages Altasciences to Perform Key Study for HT-KIT Cancer Fighting Therapeuticfinanznachrichten.de - February 26 at 10:11 AMHoth Therapeutics Partners Altasciences For Study On HT-KIT Cancer Treatmentmarkets.businessinsider.com - February 26 at 10:11 AMHoth Therapeutics Engages Altasciences to Perform Key Study for HT-KIT Cancer Fighting Therapeuticprnewswire.com - February 26 at 8:11 AMHoth Therapeutics to Attend BIO CEO and Investor Conference, February 26-27, 2024finance.yahoo.com - February 13 at 4:54 PMBuy Rating for Hoth Therapeutics: Promising HT-001 Prospects and Diverse Clinical Pipelinemarkets.businessinsider.com - February 6 at 1:47 PMHoth Therapeutics, Inc.: Hoth Therapeutics Announces it Received FDA Approval to Expand HT-001 Clinical Trial to Treat Severely Ill Patientsfinanznachrichten.de - January 18 at 1:38 PMHoth Therapeutics Received FDA Clearance To Broaden HT-001 Clinical Trialmarkets.businessinsider.com - January 18 at 1:38 PMHoth Therapeutics Shares Rise 14% After FDA Clearance for HT-001 Trial Amendmentsmarketwatch.com - January 18 at 1:38 PMHoth stock jumps on FDA approval of study expansion for HT-001msn.com - January 18 at 1:38 PMHoth Therapeutics Announces it Received FDA Approval to Expand HT-001 Clinical Trial to Treat Severely Ill Patientsfinance.yahoo.com - January 18 at 8:38 AMHoth Therapeutics, SCWorx among healthcare moversmsn.com - December 27 at 12:28 PMWhy Hoth Therapeutics Shares Are Rising Todaymsn.com - December 27 at 12:28 PMHoth Therapeutics Announces Expansion of FDA Cleared First-In-Human Clinical Trial For Cancer Patients of HT-001 at University of Miamifinance.yahoo.com - December 27 at 12:28 PMHoth Therapeutics Inc Ordinary Shares HOTHmorningstar.com - December 22 at 7:48 PMHoth Therapeutics Inc Ordinary Sharesmorningstar.com - December 12 at 7:50 PMHoth Therapeutics Announces it Has Successfully Completed Manufacturing of its Cancer fighting HT-KIT for IND-Enabling Studiesfinance.yahoo.com - December 5 at 1:28 PMHoth Completes Pre-IND Meeting With FDA On Development Of HT-KIT Therapeuticmarkets.businessinsider.com - November 14 at 2:11 PMHoth Therapeutics Announces Successful Completion of Pre-IND Meeting with FDA Regarding Development of Hoth's Cancer Fighting HT-KITfinance.yahoo.com - November 14 at 9:10 AMHoth Therapeutics to Present at NobleCon's 19th Annual Emerging Growth Investor Conference, December 3-5, 2023finance.yahoo.com - November 10 at 8:13 AMHoth Therapeutics Announces Merveille.ai Artificial intelligence Initiative for Drug Discoveryfinance.yahoo.com - October 5 at 1:01 PMHoth Therapeutics: FDA Grants Pre-IND Meeting For HT-KIT; Stock Surgesmarkets.businessinsider.com - October 2 at 9:34 AMFDA Grants Hoth Therapeutics Pre-IND Meeting for HT-KIT, Treatment for Cancer Patientsfinance.yahoo.com - October 2 at 9:34 AMEF Hutton Maintains Hoth Therapeutics (HOTH) Buy Recommendationnasdaq.com - September 15 at 4:32 PMHoth Therapeutics Announces Closing of $2.89 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rulesfinance.yahoo.com - September 15 at 4:32 PMHoth Therapeutics Reports Positive Preclinical Results Of HT-KIT Therapeutic; Stock Surgesmarkets.businessinsider.com - September 13 at 3:58 PMHoth Therapeutics Shares Rise 7% After Positive Study Data for HT-KITmarketwatch.com - September 13 at 3:58 PMHoth stock tumbles on $2.9M direct offering, private placementmsn.com - September 13 at 3:58 PMHoth Therapeutics Shares Drop 23% After Direct Offering Pricesmarketwatch.com - September 13 at 3:58 PMHoth Therapeutics' Investigational Cancer Drug Shows Encouraging Preclinical Activity In Stomach Cancersmsn.com - September 13 at 3:58 PMHoth Therapeutics Announces Positive Results Killing Cancer Cells in Both Gastrointestinal Stromal Tumors and Acute Myeloid Leukemiafinance.yahoo.com - September 13 at 3:58 PMHoth Therapeutics Announces $2.89 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rulesfinance.yahoo.com - September 13 at 3:58 PMHoth Therapeutics' Pre-IND Submission For HT-KIT For Advance Systemic Mastocytosis Accepted By FDAmarkets.businessinsider.com - September 11 at 1:17 PMHoth Therapeutics Announces FDA Accepts Pre-Investigational New Drug (Pre-IND) Submission for HT-KIT, Treatment for Cancer Patientsfinance.yahoo.com - September 11 at 1:17 PMHoth Therapeutics Reports Positive Results From Phase 1b Trial Of BioLexamarkets.businessinsider.com - September 6 at 2:22 PMHoth Therapeutics Announces Positive Final Results from 14-day Phase 1b Clinical Trial of BioLexafinance.yahoo.com - September 6 at 2:22 PMHoth Therapeutics Alzheimer's Treatment Shows Improvement In Cognitive Function, Anxietymsn.com - August 9 at 1:22 PMHoth Therapeutics Announces Positive Preclinical End Point Results of HT-ALZ Treatment for Alzheimer's Diseasefinance.yahoo.com - August 9 at 8:22 AM Get Hoth Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for HOTH and its competitors with MarketBeat's FREE daily newsletter. Email Address Tech GIANT’s Plans to Revolutionize Crypto… (Ad)A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. HOTH Media Mentions By Week HOTH Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HOTH News Sentiment▼0.000.36▲Average Medical News Sentiment HOTH News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HOTH Articles This Week▼01▲HOTH Articles Average Week Get Hoth Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for HOTH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Kintara Therapeutics News Protagenic Therapeutics News Kineta News Processa Pharmaceuticals News Ainos News PaxMedica News Hillstream BioPharma News Kazia Therapeutics News Sonnet BioTherapeutics News Lixte Biotechnology News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:HOTH) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaDems have chosen Biden replacement?Paradigm PressThis 1 Biotech Stock has been shocking the marketsHuge AlertsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithUrgent Nvidia WarningAltimetryTrump’s “Tax Free” Retirement Strategy Gold Safe Exchange Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hoth Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
